Toremifene in the treatment of breast cancer

doi:10.5306/wjco.v5.i3.393

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8099)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-5) series.

Item

Count

PDF

492

WORD

242

HTML

4959

Figures (1-4)

195

Tables (1-5)

232

Sum=6120

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

995

Download

984

Sum=1979

Aug 10, 2014 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (30)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Clin Oncol. Aug 10, 2014; 5(3): 393-405
Published online Aug 10, 2014. doi: 10.5306/wjco.v5.i3.393

Full Size Figure Download Figure

Figure 1 Time from randomization to recurrence in estrogen-receptor positive invasive breast cancer patients receiving adjuvant toremifene or tamoxifen[33].

Citation: Mustonen MV, Pyrhönen S, Kellokumpu-Lehtinen PL. Toremifene in the treatment of breast cancer. World J Clin Oncol 2014; 5(3): 393-405
URL: https://www.wjgnet.com/2218-4333/full/v5/i3/393.htm
DOI: https://dx.doi.org/10.5306/wjco.v5.i3.393